Merck to present new data highlighting research advancements across its HIV prevention ...
|
Pifeltro is indicated in combination with other antiretroviral
(ARV) agents for the treatment of HIV-1 infection in adult patients with no
prior ... |
Nigeria : New HIV Drug May Exclude Vulnerable Populations
The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...